Search Results For ''

  • Crowd Media showcases disruptive potential with 100% digitally produced doppelganger

    Within their latest Proof of Concept, artificial intelligence company Crowd Media (ASX: CM8) has showcased the interactive capabilities of its conversational commerce platform where digital avatars of celebrities and influencers can interact with fans, offer advice and unlock new commercial opportunities. In their latest public release of ‘Digital Dom’ – a 100% synthetically produced version

    Read More
    Public
  • Epsilon to provide medicinal cannabis for clinical study in children

    A hot topic in medical research at the moment, medicinal cannabis studies are being carried out for seemingly any and all ailments. One such trial being run by the Murdoch Children’s Research Institute (MCRI) is extending efficacy studies of cannabidiol medicine to children with intellectual disability that exhibit severe behavioural problems. To facilitate these studies,

    Read More
    Public
  • Prairie Mining commences $1.5 billion litigation against Republic of Poland

    The market cap of Prairie Mining (ASX: PDZ) could increase 30x if the small cap mining company is successful in its case against the Republic of Poland having lodged its £806 million Statement of Claim against the nation for depriving it of its investments. The claim (which is equivalent to AUD $1.5 billion or USD

    Read More
    Public
  • Is Costa Group or Lynch Group the pick of the bunch for investors?

    Mourners grabbing a bunch of roses at the supermarket en route to great aunt Dora’s funeral – or virtual send-off in the case of Victoria – would be oblivious to the complex logistics that enable a bunch of fresh blooms to be available beside the wonky trolleys every day. We guess the same applies to

    Read More
    Public
  • Pharmaxis Investor Briefing – Cancer Treatment Clinical Trials

    On 4 June, 2021, Pharmaxis (ASX: PXS) hosted an investor briefing with CEO Gary Phillips to update investors on recent achievements and future plans, plus a Q&A with attendees. Topics discussed in the briefing and question time included: Clinical trial stage progress and timelines; Anticipated news flow for 2021-2022; Commercial opportunities being explored in collaborationRead More
    Public
  • Mad Paws to acquire Waggly Club, our office dog approves

    Feeding our office dog and many other pups Australia wide with their subscription meal service, Dinner Bowl, it’s safe to say Mad Paws (ASX: MPA) understands the subscription market. The Company has today announced the acquisition of one of Australia’s largest dog treats and toys subscription business, Waggly Club. Since its inception when founded by

    Read More
    Public